Pillstats
Rx only · Powder, For Solution · Oral

Valganciclovir Hydrochloride

Brands: Valcyte · Valganciclovir Hydrochloride

8 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US8 NDCs
8 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)275891
US makers8 labelers
Packages8
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.414$0.828$1.24$1.66Dec 2025Apr 2026Jul 2026
$1.028
Latest avg · Jul 22, 2026
-14%
Since Dec 17, 2025
8
Active US suppliers
25%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

3897781.2K1.6K2025 Q12025 Q22025 Q32025 Q42026 Q1
763
Rx · 2026 Q1
162K
Units dispensed
-44%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it8 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Actavis Pharma, Inc.unknown1SUPPLYING
NorthStar RxLLCunknown1SUPPLYING
AvKAREunknown1SUPPLYING
Aurobindo Pharma Limitedunknown1SUPPLYING
Ajanta Pharma USA Inc.unknown1SUPPLYING
Camber Pharmaceuticals, Inc.unknown1SUPPLYING
American Health Packagingunknown1SUPPLYING
H2-Pharma, LLCunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Nov 4, 2019
    RECALLRecall (Class II): Valganciclovir Hydrochloride for Oral Solution, 50 mg/mL, 100 mL (3.4 fl. oz.) bottle, Rx only, Manufactured for: Actav…

    Presence of foreign substance: Brown/black particles found during stability testing. — Recalling firm: Teva Pharmaceuticals USA, Inc. — Product was distributed to wholesalers/distributors throughout the United States.